Han, M.; Liu, X.; Hailati, S.; Nurahmat, N.; Dilimulati, D.; Baishan, A.; Aikebaier, A.; Zhou, W.
Evaluation of the Efficacy of OSU-2S in the Treatment of Non-Small-Cell Lung Cancer and Screening of Potential Targets of Action. Pharmaceuticals 2024, 17, 582.
https://doi.org/10.3390/ph17050582
AMA Style
Han M, Liu X, Hailati S, Nurahmat N, Dilimulati D, Baishan A, Aikebaier A, Zhou W.
Evaluation of the Efficacy of OSU-2S in the Treatment of Non-Small-Cell Lung Cancer and Screening of Potential Targets of Action. Pharmaceuticals. 2024; 17(5):582.
https://doi.org/10.3390/ph17050582
Chicago/Turabian Style
Han, Mengyuan, Xiangran Liu, Sendaer Hailati, Nurbiya Nurahmat, Dilihuma Dilimulati, Alhar Baishan, Alifeiye Aikebaier, and Wenting Zhou.
2024. "Evaluation of the Efficacy of OSU-2S in the Treatment of Non-Small-Cell Lung Cancer and Screening of Potential Targets of Action" Pharmaceuticals 17, no. 5: 582.
https://doi.org/10.3390/ph17050582
APA Style
Han, M., Liu, X., Hailati, S., Nurahmat, N., Dilimulati, D., Baishan, A., Aikebaier, A., & Zhou, W.
(2024). Evaluation of the Efficacy of OSU-2S in the Treatment of Non-Small-Cell Lung Cancer and Screening of Potential Targets of Action. Pharmaceuticals, 17(5), 582.
https://doi.org/10.3390/ph17050582
